Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to ...
Zacks Investment Research on MSN
PCRX's Iovera Outperforms RFA Therapy in Pilot Study for Low Back Pain
Pacira BioSciences PCRX announced results from a pilot study evaluating the unique therapeutic approach of its iovera system ...
It's not only cosmetic procedures that are getting more subtle. Non-opioid pain management options are transforming recovery, ...
New data published in Pain Physician shows significant improvement in functional outcomes with iovera° ---- Fewer iovera° ...
The unblinded, single-center pilot study evaluated patients with facet-mediated CLBP who were randomized to receive either ...
Everyday Health on MSN
What are peptide injections?
TB-500, and copper peptide to build muscle, rejuvenate skin, and boost longevity. But do they work and are they safe?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback